Advertisement

Topics

Merck KgaA Q2 Profit Climbs, Maintains FY17 Earnings Forecast; Trims Sales View

04:51 EDT 3 Aug 2017 | FinanzNachrichten

BERLIN (dpa-AFX) - German drug major Merck KgaA (MKGAY.PK) reported Thursday higher net profit in its second quarter with increased sales. The company generated improved sales in Healthcare and Li...

Original Article: Merck KgaA Q2 Profit Climbs, Maintains FY17 Earnings Forecast; Trims Sales View

NEXT ARTICLE

More From BioPortfolio on "Merck KgaA Q2 Profit Climbs, Maintains FY17 Earnings Forecast; Trims Sales View"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...